Lisinopril 10 mg tablets — Class II drug recall D-1538-2022
Terminated recall by RemedyRepack Inc., reported 2022-09-21, distributed in AK, PA. Presence of Foreign Substance: Foreign material (metal piece) embedded in one tablet.
| Recall number | D-1538-2022 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | RemedyRepack Inc., Indiana, PA, United States |
| Recall initiated | 2022-09-15 |
| Classified | 2022-09-15 |
| Reported by FDA | 2022-09-21 |
| Terminated | 2022-11-16 |
| Distributed | AK, PA |
| Reason classes | foreign material |
| NDC | 68180-0980-03, 70518-0468-00 |
| Lot numbers | J0636336-073022, J0637605-080422 |
| Expiration dates | 2023-08-31 |
Product
Lisinopril 10 mg tablets, 30-count Blister Card, Rx Only, MFG: Lupin Pharma, Baltimore, MD Repackaged by: RemedyRepack Inc, Indiana PA. Original NDC# 68180-0980-03, Repackaged NDC# 70518-0468-00
Reason for recall
Presence of Foreign Substance: Foreign material (metal piece) embedded in one tablet.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1538-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.